Autoimmune dementia: predicting antibodies in new cognitive decline
Part of Brain & nervous system, Mental health clinical trials.
This study looks for certain antibodies that might be causing your new memory or thinking problems. It aims to find patterns that could help diagnose autoimmune dementia earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 90 years old
- You have been diagnosed with a new cognitive disorder (like memory loss or confusion) that started within the last 2 years
- You do not have a history of seizures that began in the 4 weeks after your symptoms started
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a simple blood test can help diagnose Alzheimer's disease and predict how the disease will progress. If you have memory or thinking problems that have been getting worse, you may be able to join.
This study is testing whether simple blood tests can help doctors better understand the type and progression of memory or thinking problems in people with early dementia. It aims to improve confidence in the diagnosis and future outlook.
This research study tests new blood tests that may detect early signs of Alzheimer's disease in people who currently have normal thinking and memory. By participating, you help researchers understand who might be at risk and develop better ways to predict the disease early.
This trial looks for new ways to diagnose memory and thinking problems earlier. It involves a memory test, brain scan, and blood draw to find markers that could help identify cognitive disorders.
This study is looking for older adults (60+) to help researchers better understand how to detect and track memory changes and dementia. Participants will provide blood samples and other health information over time to identify new markers that might help with early diagnosis.
This study tests whether a special 3Tesla MRI scan can improve how well antibody treatments work for people with early Alzheimer's disease. The goal is to see if the scan helps make the treatment more effective and safer.
Hear when a new Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.